Population pharmacokinetics of nintedanib, an inhibitor of tyrosine kinases, in patients with non-small cell lung cancer or idiopathic pulmonary fibrosis.
about
Population pharmacokinetics of nintedanib, an inhibitor of tyrosine kinases, in patients with non-small cell lung cancer or idiopathic pulmonary fibrosis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Population pharmacokinetics of ...... idiopathic pulmonary fibrosis.
@en
Population pharmacokinetics of ...... idiopathic pulmonary fibrosis.
@nl
type
label
Population pharmacokinetics of ...... idiopathic pulmonary fibrosis.
@en
Population pharmacokinetics of ...... idiopathic pulmonary fibrosis.
@nl
prefLabel
Population pharmacokinetics of ...... idiopathic pulmonary fibrosis.
@en
Population pharmacokinetics of ...... idiopathic pulmonary fibrosis.
@nl
P2093
P2860
P1476
Population pharmacokinetics of ...... idiopathic pulmonary fibrosis.
@en
P2093
Angele Fleury
Claudia Dallinger
Karl-Heinz Liesenfeld
Matthias Freiwald
Ulrike Schmid
P2860
P2888
P304
P356
10.1007/S00280-017-3452-0
P577
2017-11-08T00:00:00Z